Develops precision therapies for cancer, blood disorders & allergy/inflammation501-1000 Employees
Blueprint Medicines Funding
$0
44 rounds
Blueprint Medicines is active in the following markets / industries: biotechnology and health care. The company has secured funding across 4 rounds and is valued at $0. Their most recent funding was raised on March 4, 2015.
Funding Rounds
C
$50000000B
$25000000
A
$40000000Investors of Blueprint Medicines
Nextech Invest
Casdin Capital
Cowen Group
Wellington Management
Investment management across global public and private markets
RA Capital Management, L.P.
Invests in life-sciences and drug development companies
Alexion Pharmaceuticals
Rounds
U
F-Prime
Rounds
B
A
Wellington Management Company
Rounds
C
Tavistock Life Sciences
Rounds
C